Sentoclone International Ab

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 83.3

EPO Patents = 3

Forward Citations = 80

Loading Chart...

3 inventors (with patents filed for the assignee):

Ola Winqvist (6 out of 29 patents)

Magnus Thörn (5 out of 10 patents)

Magnus Thöm (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8709404 - Immunotherapy in cancer treatment (2014-04-29),

2. 8211425 - Method for treating disseminated cancer (2012-07-03),

3. 8211424 - Method for treating malignant melanoma (2012-07-03),

4. 8206702 - Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer (2012-06-26),

5. 8101173 - Method for treating urinary bladder cancer (2012-01-24),

6. 8007785 - Method for treating colon cancer with tumour-reactive T-lymphocytes (2011-08-30),

Company Overview

Sentoclone International Ab is a leading biotechnology company specializing in innovative gene editing technologies. With a strong focus on precision medicine, our mission is to develop personalized therapies for a wide range of diseases. We offer cutting-edge solutions for genetic engineering and cell therapy, enabling researchers and clinicians to unlock the potential of gene therapy in healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#129 in Stockholm

#931 in Sweden

Stockholm, Sweden

Sentoclone International Ab

Forward Citations = 80

3 inventors:

Ola Winqvist (6 out of 29 patents)

Magnus Thörn (5 out of 10 patents)

Magnus Thöm (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sentoclone International Ab. Retrieved from https://idiyas.com/company/sentoclone-international-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]